跳转至内容
Merck

92301

Millipore

单核细胞增多性李斯特菌选择性添加剂 I

suitable for microbiology

别名:

多粘菌素 B 硫酸盐, 单核细胞增生李斯特菌选择性添加剂 I

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C55H96N16O13 · 2H2SO4
CAS号:
分子量:
1385.61
EC 号:
MDL编号:
UNSPSC代码:
41106200
NACRES:
NA.85

无菌性

sterile

质量水平

表单

powder

保质期

limited shelf life, expiry date on the label

抗生素抗菌谱

Gram-negative bacteria
Gram-positive bacteria
fungi

应用

environmental
food and beverages

microbiology

作用机制

cell membrane | interferes

储存温度

2-8°C

适用性

Listeria spp.

SMILES字符串

O=C(C(NC(C(CCN)NC(CCCCC(C)CC)=O)=O)C(C)O)NC(CCN)C(NC(CCNC(C(NC(C(NC(C(CCN)N1)=O)CCN)=O)C(O)C)=O)C(NC(CCN)C(NC(CC2=CC=CC=C2)C(NC(CC(C)C)C1=O)=O)=O)=O)=O.O=S(O)(O)=O

InChI

1S/C48H82N16O13.H2O4S/c1-27(2)24-37-47(76)59-32(11-19-52)41(70)56-31(10-18-51)43(72)61-35(14-22-65)39(68)54-21-13-34(45(74)57-33(12-20-53)44(73)64-38(48(77)63-37)25-28-6-4-3-5-7-28)60-42(71)30(9-17-50)58-46(75)36(15-23-66)62-40(69)29(8-16-49)55-26-67;1-5(2,3)4/h3-7,26-27,29-38,65-66H,8-25,49-53H2,1-2H3,(H,54,68)(H,55,67)(H,56,70)(H,57,74)(H,58,75)(H,59,76)(H,60,71)(H,61,72)(H,62,69)(H,63,77)(H,64,73);(H2,1,2,3,4)

InChI key

HNDFYNOVSOOGDU-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

由 ISO 委员会建议用于分离李斯特菌的选择性添加剂。
Chemical structure: peptide

应用

for the isolation of Listeria species

生化/生理作用

作用机制:多粘菌素B硫酸盐结合到细菌脂多糖的脂质部分†上,通过诱导足够大的孔来破坏细胞质膜,使核苷酸泄漏到细菌的细胞壁中。 这可破环细胞质膜的半透性。

抗菌谱:对大多数革兰氏阴性杆菌,包括 大肠杆菌 ,真菌和革兰氏阳性菌都有杀菌作用。

组分

(每瓶,足够用于 500mL 培养基)
硫酸多粘菌素 B 38350IU

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Kensuke Nakamura et al.
The American journal of emergency medicine, 31(5), 893-893 (2013-02-13)
Septic patients often have low cardiac output. Some of them present severe cardiac dysfunction such as septic cardiomyopathy. However, no well-known and effective treatment for septic cardiomyopathy exists. The effect of endotoxin adsorption by polymyxin B–immobilized fiber column–direct hemoperfusion (PMX-DHP)
Conjugated polymer-coated bacteria for multimodal intracellular and extracellular anticancer activity.
Chunlei Zhu et al.
Advanced materials (Deerfield Beach, Fla.), 25(8), 1203-1208 (2013-01-03)
Lee Sun New et al.
Analytical and bioanalytical chemistry, 405(4), 1407-1415 (2012-11-28)
With increasing multidrug resistance coupled to a poor development pipeline, clinicians are exploring antimicrobial combinations to improve treatment outcomes. In vitro hollow-fiber infection model (HFIM) is employed to simulate human in vivo drug clearance and investigate pharmacodynamic synergism of antibiotics.
The novel polymyxin derivative NAB739 is remarkably less cytotoxic than polymyxin B and colistin to human kidney proximal tubular cells.
Martti Vaara et al.
International journal of antimicrobial agents, 41(3), 292-293 (2012-11-28)
Naoki Sawa et al.
Clinical nephrology, 79(6), 463-470 (2012-12-21)
Vasopressin and direct hemoperfusion with an immobilized polymyxin B column (PMX) have emerged recently as treatments for septic shock. This study assessed the impact of these two treatments on the survival of patients with septic shock. A retrospective, matched cohort

实验方案

近年来,李斯特菌病被定为重大的公共健康问题。这种病的主要感染对象是老年人、孕妇、新生儿和免疫功能低下者。

Listeria is a public health concern, affecting elderly, pregnant, newborns, and immunocompromised individuals.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门